151 related articles for article (PubMed ID: 2953718)
1. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.
Fukuda MN; Dell A; Scartezzini P
J Biol Chem; 1987 May; 262(15):7195-206. PubMed ID: 2953718
[TBL] [Abstract][Full Text] [Related]
2. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.
Fukuda MN; Masri KA; Dell A; Luzzatto L; Moremen KW
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7443-7. PubMed ID: 2217175
[TBL] [Abstract][Full Text] [Related]
3. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
Fukuda MN; Masri KA; Dell A; Thonar EJ; Klier G; Lowenthal RM
Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036
[TBL] [Abstract][Full Text] [Related]
4. HEMPAS disease: genetic defect of glycosylation.
Fukuda MN
Glycobiology; 1990 Sep; 1(1):9-15. PubMed ID: 2136385
[TBL] [Abstract][Full Text] [Related]
5. Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes.
Dhume ST; Adams-Burton CR; Shumak KH; Laine RA
Glycobiology; 1994 Dec; 4(6):903-8. PubMed ID: 7734852
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of poly-N-acetyllactosaminylceramides accumulated in the erythrocytes of congenital dyserythropoietic anemia type II patients.
Fukuda MN; Bothner B; Scartezzini P; Dell A
Chem Phys Lipids; 1986 Dec; 42(1-3):185-97. PubMed ID: 3829205
[TBL] [Abstract][Full Text] [Related]
7. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
Fukuda MN
Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
[TBL] [Abstract][Full Text] [Related]
8. Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS).
Fukuda MN; Papayannopoulou T; Gordon-Smith EC; Rochant H; Testa U
Br J Haematol; 1984 Jan; 56(1):55-68. PubMed ID: 6538436
[TBL] [Abstract][Full Text] [Related]
9. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.
Fukuda MN
Biochim Biophys Acta; 1999 Oct; 1455(2-3):231-9. PubMed ID: 10571015
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).
Charuk JH; Tan J; Bernardini M; Haddad S; Reithmeier RA; Jaeken J; Schachter H
Eur J Biochem; 1995 Jun; 230(2):797-805. PubMed ID: 7607254
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional consequences of an N-glycosylation mutation (HEMPAS) affecting human erythrocyte membrane glycoproteins.
Kameh H; Landolt-Marticorena C; Charuk JH; Schachter H; Reithmeier RA
Biochem Cell Biol; 1998; 76(5):823-35. PubMed ID: 10353717
[TBL] [Abstract][Full Text] [Related]
12. Structure of fetal lactosaminoglycan. The carbohydrate moiety of Band 3 isolated from human umbilical cord erythrocytes.
Fukuda M; Dell A; Fukuda MN
J Biol Chem; 1984 Apr; 259(8):4782-91. PubMed ID: 6715323
[TBL] [Abstract][Full Text] [Related]
13. Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS).
Fukuda MN; Gaetani GF; Izzo P; Scartezzini P; Dell A
Br J Haematol; 1992 Dec; 82(4):745-52. PubMed ID: 1482662
[TBL] [Abstract][Full Text] [Related]
14. Anomalous clustering of underglycosylated band 3 in erythrocytes and their precursor cells in congenital dyserythropoietic anemia type II.
Fukuda MN; Klier G; Yu J; Scartezzini P
Blood; 1986 Aug; 68(2):521-9. PubMed ID: 3730615
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).
Denecke J; Kranz C; Nimtz M; Conradt HS; Brune T; Heimpel H; Marquardt T
Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993
[TBL] [Abstract][Full Text] [Related]
16. Aberrant regulation of complement by the erythrocytes of hereditary erythroblastic multinuclearity with a positive acidified serum lysis test (HEMPAS).
Tomita A; Parker CJ
Blood; 1994 Jan; 83(1):250-9. PubMed ID: 7506081
[TBL] [Abstract][Full Text] [Related]
17. Structure of sialylated fucosyl lactosaminoglycan isolated from human granulocytes.
Fukuda M; Spooncer E; Oates JE; Dell A; Klock JC
J Biol Chem; 1984 Sep; 259(17):10925-35. PubMed ID: 6432790
[TBL] [Abstract][Full Text] [Related]
18. Control of glycoprotein synthesis. Detection and characterization of a novel branching enzyme from hen oviduct, UDP-N-acetylglucosamine:GlcNAc beta 1-6 (GlcNAc beta 1-2)Man alpha-R (GlcNAc to Man) beta-4-N-acetylglucosaminyltransferase VI.
Brockhausen I; Hull E; Hindsgaul O; Schachter H; Shah RN; Michnick SW; Carver JP
J Biol Chem; 1989 Jul; 264(19):11211-21. PubMed ID: 2525556
[TBL] [Abstract][Full Text] [Related]
19. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.
Zdebska E; Mendek-Czajkowska E; Ploski R; Woêniewicz B; Koscielak J
Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161
[TBL] [Abstract][Full Text] [Related]
20. Congenital disorders involving defective N-glycosylation of proteins.
Schachter H
Cell Mol Life Sci; 2001 Jul; 58(8):1085-104. PubMed ID: 11529501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
